SEQLL INC (SQL)
US81734C3043 - Common Stock
Overall SQL gets a fundamental rating of 2 out of 10. We evaluated SQL against 56 industry peers in the Life Sciences Tools & Services industry. The financial health of SQL is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SQL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SQL had negative earnings in the past year.
SQL had a negative operating cash flow in the past year.
In the past 5 years SQL always reported negative net income.
SQL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SQL has a worse Return On Assets (-79.09%) than 91.80% of its industry peers.
SQL's Return On Equity of -181.20% is on the low side compared to the rest of the industry. SQL is outperformed by 90.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -79.09% | ||
| ROE | -181.2% | ||
| ROIC | N/A |
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for SQL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SQL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQL remains at a similar level compared to 1 year ago.
SQL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SQL is higher compared to a year ago.
2.2 Solvency
SQL has an Altman-Z score of -6.09. This is a bad value and indicates that SQL is not financially healthy and even has some risk of bankruptcy.
SQL has a worse Altman-Z score (-6.09) than 91.80% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that SQL is somewhat dependend on debt financing.
The Debt to Equity ratio of SQL (0.50) is worse than 73.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.09 |
ROIC/WACCN/A
WACC11.75%
2.3 Liquidity
A Current Ratio of 5.04 indicates that SQL has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.04, SQL is doing good in the industry, outperforming 70.49% of the companies in the same industry.
SQL has a Quick Ratio of 5.04. This indicates that SQL is financially healthy and has no problem in meeting its short term obligations.
SQL's Quick ratio of 5.04 is fine compared to the rest of the industry. SQL outperforms 75.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.04 | ||
| Quick Ratio | 5.04 |
3. Growth
3.1 Past
The earnings per share for SQL have decreased strongly by -3588.50% in the last year.
Looking at the last year, SQL shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
The Revenue for SQL have been decreasing by -43.28% on average. This is quite bad
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%
3.2 Future
SQL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.17% yearly.
SQL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 354.84% yearly.
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SQL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SQL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SQL's earnings are expected to grow with 25.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.64%
EPS Next 3Y25.17%
5. Dividend
5.1 Amount
SQL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEQLL INC
NASDAQ:SQL (11/13/2023, 8:16:47 PM)
After market: 4.9999 -1.6 (-24.23%)6.5991
-1.67 (-20.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.28%
Inst Owner Change-99.58%
Ins Owners6727.96%
Ins Owner Change0%
Market Cap2.51M
Analysts80
Price Target3.06 (-53.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.86 | ||
| P/tB | 0.86 | ||
| EV/EBITDA | N/A |
EPS(TTM)-13.6
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-12.25
FCFYN/A
OCF(TTM)-12.06
OCFYN/A
SpS0
BVpS7.67
TBVpS7.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -79.09% | ||
| ROE | -181.2% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 58.35% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.04 | ||
| Quick Ratio | 5.04 | ||
| Altman-Z | -6.09 |
F-Score1
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A
EBIT growth 1Y-48.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.06%
OCF growth 3YN/A
OCF growth 5YN/A